SCHEMBL3760600

SCHEMBL3760600

CNC(=O)c1ccc(-c2cc(-c3c(N4CCOCC4)sc4c3CC(C)(C)CC4=O)ccn2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 7/20 0.40
KDM1A O60341 4/20 0.40
CHEK1 O14757 1/20 0.38
MTOR P42345 3/20 0.38
PIK3CA P42336 3/20 0.38
PIK3CG P48736 2/20 0.38
PIK3R1 P27986 1/20 0.38
BUB1 O43683 2/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CB P42338 1/20 0.36
JAK2 O60674 4/20 0.36
JAK3 P52333 4/20 0.36
JAK1 P23458 3/20 0.36
TYK2 P29597 3/20 0.36
HDAC3 O15379 1/20 0.36
NCOR1 O75376 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
BMPR1B O00238 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3764901 0.93 PIK3CA (0.41) HDAC1KDM1ACHEK1MTORPIK3CA
SCHEMBL16161825 0.90 JAK2 (0.41) HDAC1KDM1ACHEK1PIK3CAPIK3CG
SCHEMBL3761949 0.89 HSD17B10 (0.42) HDAC1KDM1AMTORPIK3CAPIK3CG
SCHEMBL3759201 0.88 PIK3CD (0.39) PIK3CAPIK3CGBUB1PIK3CDPIK3CB
SCHEMBL3758765 0.87 PIK3CA (0.40) PIK3CAPIK3CGPIK3R1BUB1PIK3CD
SCHEMBL3756839 0.87 JAK2 (0.45) MTORPIK3CAPIK3CGPIK3R1BUB1
SCHEMBL3759257 0.87 PIK3CA (0.40) MTORPIK3CAPIK3CGBUB1PIK3CD
SCHEMBL3762353 0.87 PIK3CD (0.39) MTORPIK3CAPIK3CGPIK3R1BUB1
SCHEMBL3764482 0.86 BUB1 (0.44) PIK3CAPIK3CGBUB1PIK3CDPIK3CB
SCHEMBL3760904 0.86 ABL1 (0.39) HDAC1KDM1AMTORPIK3CAPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA HDAC1 669/4885KDM1A 3543/4885CHEK1 102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.